Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-25

Clinical Trial Update: Social Determinants and a Diabetes Prevention Program Tailored for African Americans [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial from the University of Missouri, Kansas City is evaluating a diabetes prevention program tailored to African Americans that addresses s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Missouri, Kansas City | Conditions: PreDiabetes, Overweight and Obesity | Phase 2 | Status: RECRUITING